Cargando…
Biomarkers in colorectal liver metastases: Rising complexity and unknown clinical significance?
Surgical resection of the liver is the standard treatment for colorectal liver metastases, but 70% of patients still experience recurrence, resulting in limited survival. Molecular biomarkers promise guidance within the selection process of individualized treatment and provide better prognostic fore...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316735/ https://www.ncbi.nlm.nih.gov/pubmed/34337296 http://dx.doi.org/10.1002/ags3.12454 |